Shares of Vertex Pharmaceuticals Incorporated VRTX were down 11.4% yesterday after the company announced data from a phase II ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced results from its Phase 2 study of suzetrigine, an investigational, oral, highly selective NaV1.8 pain signal inhibitor in people with ...

Additionally, our team of experts has vetted each service on our list. Read more about how we vet brands and products we include in our content. If you opt for online STI treatment, you can often ...

Neuropathy affects nearly 25 million Americans every day and the typical solution only masks the problem without getting to ...

These are typically drugs that may be especially harmful and, in some cases, fatal with just one dose if they are used by someone other than the person for whom the medicine was prescribed. You can ...

Carbamazepine is also often used for the treatment of pain that is related to conditions such as neuropathy and trigeminal neuralgia. It comes in a capsule, pill, and oral liquid form. Carbamazepine ...

Conventional radiation treatment might slow their growth, but Carter was certain to die. Then his doctors gave him pembrolizumab (Keytruda), a new immunotherapy medication that could spur a ...

While age is a factor, certain medications like Benadryl, opiates, and omeprazole, if used long-term, might increase dementia risk. Always consult your doctor before making medication changes.

A new form of treatment for serious asthma and chronic obstructive pulmonary disease (COPD) could be “a game changer” for patients, according to respiratory experts. Doctors said the new way ...

He would refuse treatment when he was using. Garcia’s story eventually became the catalyst for Washington state to bring in Ricky’s Law in 2018, which gives the state the power to force ...

Scientists have found a new treatment for people with asthma and chronic obstructive pulmonary disease (COPD) that may be more effective than current options. Over the past 50 years, treatment ...

Roughly one-third of the Department of Veterans Affairs' projected medical budget shortfall in 2025 is due to the costs of new medications, including weight-loss drugs like Wegovy and Zepbound ...